Use of Ghrelin as a Treatment for Inflammatory Bowel Disease: Mechanistic Considerations

Inflammatory bowel diseases (IBD)—and in particular Crohn's disease—are immune-mediated processes that result in denuded intestinal mucosa and can produce decreased appetite, weight loss, and systemic inflammation. Current treatments include anti-inflammatory medications, immunomodulators, and...

Descripción completa

Detalles Bibliográficos
Autor principal: DeBoer, Mark D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154487/
https://www.ncbi.nlm.nih.gov/pubmed/21845198
http://dx.doi.org/10.1155/2011/189242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154487/
https://www.ncbi.nlm.nih.gov/pubmed/21845198
http://dx.doi.org/10.1155/2011/189242

Ejemplares similares